25 October 2019 - The Deputy Commissioner of the Chinese National Medical Product Administration, Dr Chen Shifei, visited EMA on 25 October together with a delegation.

The visit took place in the context of the ongoing EU-China regulatory dialogue on pharmaceuticals. 

Topics for discussion between Guido Rasi, EMA's Executive Director, Andrzej Rys, Director responsible for Health Systems, Medical Products and Innovation at the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) and Dr Shifei included good manufacturing practice (GMP) standards for active pharmaceutical ingredients, good clinical practice (GCP) standards, and the Commission’s strategic approach to pharmaceuticals in the environment.

Read EMA press release